SCHEMBL9511570

SCHEMBL9511570

C=C(C)C(=O)OCCCOC(=O)/C(C)=C(/C)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.56
THRB P10828 1/20 0.48
POLB P06746 1/20 0.46
APEX1 P27695 1/20 0.46
HTT P42858 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
ALDH1A1 P00352 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9514375 0.96 TSHR (0.61) TSHRTHRBPOLBAPEX1HTT
SCHEMBL9512062 0.92 THRB (0.57) TSHRTHRBPOLBAPEX1HTT
SCHEMBL182045 0.85 TSHR (0.72) TSHRTHRBPOLBAPEX1HTT
SCHEMBL10953665 0.84 TSHR (0.60) TSHRTHRBPOLBAPEX1HTT
Methacrylic Acid SCHEMBL28574150 0.84 TSHR (0.70) TSHRTHRBPOLBAPEX1HTT
Methacrylic Acid SCHEMBL11120335 0.84 TSHR (0.70) TSHRTHRBPOLBAPEX1HTT
SCHEMBL9162964 0.83 TSHR (0.69) TSHRTHRBPOLBAPEX1HTT
SCHEMBL11600594 0.83 TSHR (0.69) TSHRTHRBPOLBAPEX1HTT
Methacrylic Acid SCHEMBL19252958 0.82 TSHR (0.74) TSHRTHRBPOLBAPEX1HTT
SCHEMBL9623489 0.82 TSHR (0.62) TSHRTHRBPOLBAPEX1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10004673-B1 Hair treatment composition comprising Michael addition product and methods for treating hair L'OREAL (FR) 2018-06-26 US claimed
EP-0325038-B1 Surface priming composition for proteinaceous substrates, method of making and using same OPI PROD INC (US) 1993-11-03 EP claimed
US-4913939-A Reaction product of cyclic anhydride and hydroxy compound; adhesion of adhesives REM SYSTEMS, INC. (US) 1990-04-03 US claimed
US-4863993-A Surface priming composition for proteinaceous substrates; method of making and using same OPI PRODUCTS, INC. (US) 1989-09-05 US claimed
EP-0325038-A2 Surface priming composition for proteinaceous substrates, method of making and using same OPI PRODUCTS, INC. (US) 1989-07-26 EP claimed
US-10004673-B1 Hair treatment composition comprising Michael addition product and methods for treating hair L'OREAL (FR) 2018-06-26 US disclosed
EP-0325038-B1 Surface priming composition for proteinaceous substrates, method of making and using same OPI PROD INC (US) 1993-11-03 EP disclosed
US-4913939-A Reaction product of cyclic anhydride and hydroxy compound; adhesion of adhesives REM SYSTEMS, INC. (US) 1990-04-03 US disclosed
US-4863993-A Surface priming composition for proteinaceous substrates; method of making and using same OPI PRODUCTS, INC. (US) 1989-09-05 US disclosed
EP-0325038-A2 Surface priming composition for proteinaceous substrates, method of making and using same OPI PRODUCTS, INC. (US) 1989-07-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10004673-B1 Hair treatment composition comprising Michael addition product and methods for treating hair SRM, CRAT, C9 TSHR 1844/4885THRB 1763/4885POLB 283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.